{"entity":{"type":"insider","cik":"0001786484","url":"/insider/0001786484","json_url":"/insider/0001786484.json","name":"Burrell Terry-Ann","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":10,"first":"2021-01-05","last":"2024-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Burrell Terry-Ann","source":"filing","n_filings":10,"first_seen":"2021-01-05","last_seen":"2024-04-03"}],"transactions":[{"id":2236202,"accession":"0000950170-24-041437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-041437","line_url":"/filing/0000950170-24-041437#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5446.0,"shares_display":"5,446","price_per_share":32.12,"price_display":"32.12","price_state":"stated","total_value":174925.52,"total_display":"174,925.52","total_whole":"174,926","shares_owned_after":70137.0,"shares_owned_after_display":"70,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":8680295,"accession":"0001209191-23-042305","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-042305","line_url":"/filing/0001209191-23-042305#line-5","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8275.0,"shares_display":"8,275","price_per_share":12.5852,"price_display":"12.59","price_state":"stated","total_value":104142.53,"total_display":"104,142.53","total_whole":"104,143","shares_owned_after":54847.0,"shares_owned_after_display":"54,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-13","filed_date":"2023-07-14","scope":"insider"},{"id":8680294,"accession":"0001209191-23-042305","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-042305","line_url":"/filing/0001209191-23-042305","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108725.0,"shares_display":"108,725","price_per_share":12.032844321913084,"price_display":"12.03","price_state":"stated","total_value":1308270.9989,"total_display":"1,308,271.00","total_whole":"1,308,271","shares_owned_after":69474.0,"shares_owned_after_display":"69,474","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-12","filed_date":"2023-07-14","scope":"insider","n_lines":4},{"id":8569472,"accession":"0000899243-23-010815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-010815","line_url":"/filing/0000899243-23-010815#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2186.0,"shares_display":"2,186","price_per_share":29.0931,"price_display":"29.09","price_state":"stated","total_value":63597.5166,"total_display":"63,597.52","total_whole":"63,598","shares_owned_after":47117.0,"shares_owned_after_display":"47,117","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":8569467,"accession":"0000899243-23-010815","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-010815","line_url":"/filing/0000899243-23-010815#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2454.0,"shares_display":"2,454","price_per_share":30.31,"price_display":"30.31","price_state":"stated","total_value":74380.74,"total_display":"74,380.74","total_whole":"74,381","shares_owned_after":49303.0,"shares_owned_after_display":"49,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8062137,"accession":"0000899243-23-002957","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-002957","line_url":"/filing/0000899243-23-002957#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36152.0,"shares_display":"36,152","price_per_share":45.0804,"price_display":"45.08","price_state":"stated","total_value":1629746.6208,"total_display":"1,629,746.62","total_whole":"1,629,747","shares_owned_after":31277.0,"shares_owned_after_display":"31,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-30","scope":"insider"},{"id":8062130,"accession":"0000899243-23-002957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002957","line_url":"/filing/0000899243-23-002957#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1102.0,"shares_display":"1,102","price_per_share":45.1572,"price_display":"45.16","price_state":"stated","total_value":49763.2344,"total_display":"49,763.23","total_whole":"49,763","shares_owned_after":31277.0,"shares_owned_after_display":"31,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-26","filed_date":"2023-01-30","scope":"insider"},{"id":8694202,"accession":"0000899243-23-002666","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-002666","line_url":"/filing/0000899243-23-002666#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14810.0,"shares_display":"14,810","price_per_share":45.014,"price_display":"45.01","price_state":"stated","total_value":666657.34,"total_display":"666,657.34","total_whole":"666,657","shares_owned_after":31277.0,"shares_owned_after_display":"31,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-25","scope":"insider"},{"id":8694193,"accession":"0000899243-23-002666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002666","line_url":"/filing/0000899243-23-002666#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5426.0,"shares_display":"5,426","price_per_share":45.0221,"price_display":"45.02","price_state":"stated","total_value":244289.9146,"total_display":"244,289.91","total_whole":"244,290","shares_owned_after":31277.0,"shares_owned_after_display":"31,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8527683,"accession":"0000899243-23-002260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002260","line_url":"/filing/0000899243-23-002260#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47195.0,"shares_display":"47,195","price_per_share":45.14,"price_display":"45.14","price_state":"stated","total_value":2130382.3,"total_display":"2,130,382.30","total_whole":"2,130,382","shares_owned_after":31277.0,"shares_owned_after_display":"31,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-20","scope":"insider"},{"id":6973833,"accession":"0000899243-22-013485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-013485","line_url":"/filing/0000899243-22-013485#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1787.0,"shares_display":"1,787","price_per_share":59.11,"price_display":"59.11","price_state":"stated","total_value":105629.57,"total_display":"105,629.57","total_whole":"105,630","shares_owned_after":38278.0,"shares_owned_after_display":"38,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-04","scope":"insider"},{"id":5031252,"accession":"0000899243-21-027313","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-027313","line_url":"/filing/0000899243-21-027313","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":122.0,"price_display":"122.00","price_state":"stated","total_value":3660000.0,"total_display":"3,660,000.00","total_whole":"3,660,000","shares_owned_after":24809.0,"shares_owned_after_display":"24,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-02","scope":"insider","n_lines":2},{"id":4868155,"accession":"0000899243-21-026779","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-026779","line_url":"/filing/0000899243-21-026779","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":107.68925466666667,"price_display":"107.69","price_state":"stated","total_value":4846016.46,"total_display":"4,846,016.46","total_whole":"4,846,016","shares_owned_after":24809.0,"shares_owned_after_display":"24,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider","n_lines":7},{"id":5087464,"accession":"0000899243-21-000430","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-000430","line_url":"/filing/0000899243-21-000430","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786484","owner_name":"Burrell Terry-Ann","owner_display_name":"Burrell Terry-Ann","owner_url":"/insider/0001786484","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":81.7793916,"price_display":"81.78","price_state":"stated","total_value":2044484.79,"total_display":"2,044,484.79","total_whole":"2,044,485","shares_owned_after":8209.0,"shares_owned_after_display":"8,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-05","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001745999","name":"Beam Therapeutics Inc.","url":"/issuer/0001745999","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2021-01-05","last_seen":"2024-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Director","n_filings":1,"first_seen":"2023-07-14","last_seen":"2023-07-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001786484","retrieved_at":"2026-08-25T04:57:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}